Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Valente

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Chemmedchem|November 21, 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer ActivityClemens Zwergel, Elisabetta Di Bello, Rossella Fioravanti, et al.
Scientific Reports|November 6, 2019
The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cellsAnnarita Favia, Luisa Salvatori, Simona Nanni, et al.
Chemmedchem|March 26, 2024
Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem CellsFrancesco Fiorentino, Emanuele Fabbrizi, Alessia Raucci, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Pharmacological Activation of SIRT3 Modulates the Response of Cancer Cells to Acidic pHMichele Aventaggiato, Tania Arcangeli, Enza Vernucci, et al.
Autoimmunity|January 21, 2016
Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine modelRosa Di Liddo, Sergio Valente, Samanta Taurone, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cellsPaolo Mellini, Biagina Marrocco, Diana Borovika, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and MitophagyFederica Barreca, Michele Aventaggiato, Mario Cristina, et al.
Cell Stem Cell|October 5, 2010
TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regenerationDaniela Palacios, Chiara Mozzetta, Silvia Consalvi, et al.
Neuroscience|March 29, 2018
Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS MiceDaniela Buonvicino, Roberta Felici, Giuseppe Ranieri, et al.
EMBO Reports|June 6, 2009
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Chemmedchem|November 21, 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer ActivityClemens Zwergel, Elisabetta Di Bello, Rossella Fioravanti, et al.
Scientific Reports|November 6, 2019
The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cellsAnnarita Favia, Luisa Salvatori, Simona Nanni, et al.
Chemmedchem|March 26, 2024
Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem CellsFrancesco Fiorentino, Emanuele Fabbrizi, Alessia Raucci, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Pharmacological Activation of SIRT3 Modulates the Response of Cancer Cells to Acidic pHMichele Aventaggiato, Tania Arcangeli, Enza Vernucci, et al.
Autoimmunity|January 21, 2016
Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine modelRosa Di Liddo, Sergio Valente, Samanta Taurone, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cellsPaolo Mellini, Biagina Marrocco, Diana Borovika, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and MitophagyFederica Barreca, Michele Aventaggiato, Mario Cristina, et al.
Cell Stem Cell|October 5, 2010
TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regenerationDaniela Palacios, Chiara Mozzetta, Silvia Consalvi, et al.
Neuroscience|March 29, 2018
Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS MiceDaniela Buonvicino, Roberta Felici, Giuseppe Ranieri, et al.
EMBO Reports|June 6, 2009
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
Pageof 16